N-Desmethylenzalutamide

From WikiMD's Medical Encyclopedia

Revision as of 01:58, 27 May 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Desmethylenzalutamide


N-Desmethylenzalutamide is a nonsteroidal antiandrogen (NSAA) that is a major active metabolite of the drug enzalutamide (brand name Xtandi). It is formed in the body through the process of demethylation of enzalutamide. N-Desmethylenzalutamide retains significant antiandrogenic activity and contributes to the overall therapeutic effects of enzalutamide in the treatment of prostate cancer.

Pharmacology[edit]

N-Desmethylenzalutamide functions by binding to the androgen receptor (AR) and inhibiting its activation by androgens such as testosterone and dihydrotestosterone (DHT). This inhibition prevents the androgen receptor from translocating to the cell nucleus and modulating the expression of androgen-responsive genes, which are involved in the growth and survival of prostate cancer cells.

Metabolism[edit]

Enzalutamide is metabolized in the liver primarily by the cytochrome P450 enzyme CYP2C8, with minor contributions from CYP3A4. The demethylation of enzalutamide to form N-Desmethylenzalutamide is a key step in its metabolic pathway. N-Desmethylenzalutamide itself is further metabolized to other inactive compounds before being excreted from the body.

Clinical Significance[edit]

The presence of N-Desmethylenzalutamide in the bloodstream of patients taking enzalutamide is an important factor in the drug's efficacy. The metabolite's antiandrogenic activity helps to sustain the suppression of androgen receptor signaling, which is crucial for the treatment of castration-resistant prostate cancer (CRPC).

Side Effects[edit]

The side effects of N-Desmethylenzalutamide are generally similar to those of enzalutamide, as both compounds act on the same target. Common side effects include fatigue, hot flashes, and hypertension. More serious side effects can include seizures and other neurological effects, which are thought to be related to the drug's ability to cross the blood-brain barrier.

See Also[edit]

References[edit]

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.